Home / News / SHL Medical / SHL returns to PFSS Tokyo 2023 this summer
Events| August 10, 2023

SHL returns to PFSS Tokyo 2023 this summer

An event participation announcement by SHL Medical titled “SHL Medical returns to PFSS Tokyo 2023 this summer” featuring Tokyo Tower
Aside from exhibiting, two of SHL Medical representatives will also speak at Tokyo

SHL Medical is excited to announce our participation in the 2023 Prefilled Syringe Seminar (PFSS) Tokyo organized by Parenteral Drug Association (PDA) Japan Chapter on September 12-13 at Sola City Conference Center.

We welcome visitors to learn more about our comprehensive manufacturing capabilities and Innovation Partnership program. Get updates from our team members on our latest offerings: the Maggie® autoinjectors for large-volume/high-dose injections and the Molly® Connected Cap for therapeutics adherence support through digital health.

We are looking forward to meeting you in Tokyo!

 
Book a meeting with us

 

When   : September 12-13, 2023

Where : Sola City Conference Center Tokyo, Japan

 

Meet our speakers!

Title Speakers Time
A literature and usability study into the impact of large-volume/high-dose drug delivery: Breaking conventional autoinjector boundaries

Gary Calderwood

Product Manager, SHL Medical

September 12

2:20 PM JST | Session C2

 Chun Chang, MSc

 Senior Usability Engineer, SHL Medical

 

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News